Skip to ContentSkip to Navigation
About us Practical matters How to find us dr. L.C.L.T. (Léon) van Kempen
University Medical Center Groningen

dr. L.C.L.T. (Léon) van Kempen

Clinical Scientist in Molecular Pathology
Profile picture of dr. L.C.L.T. (Léon) van Kempen
Telephone:
+31 50 361 5129 (Office)
Staff assistant:
+31 50 361 0020 (Mrs. Annet Bouman - Van der Jagt)
E-mail:
l.van.kempen umcg.nl

Research interests

Clinical Scientist in Molecular Pathology, molecular diagnostic service. 

Research interests: Molecular biology and pathology of melanoma and non-small cell lung cancer. 

Publications

Classification of Fibro-osseous Tumors in the Craniofacial Bones using DNA Methylation and Copy Number Alterations

Developments in predictive biomarker testing and targeted therapy in advanced stage non-small cell lung cancer and their application across European countries

External Quality Assessment on Molecular Tumor Profiling with Circulating Tumor DNA-Based Methodologies Routinely Used in Clinical Pathology within the COIN Consortium

Future perspective for the application of predictive biomarker testing in advanced stage non-small cell lung cancer

Gene expression profiling in PBMCs for acute rejection in lung transplant recipients reveals myeloid responses

Increased interferon signalling in vaginal tissue of patients with primary Sjögren's syndrome

Molecular Tumor Board of the University Medical Center Groningen (UMCG-MTB): outcome of patients with rare or complex mutational profiles receiving MTB-advised targeted therapy

Prognostic Value of KRAS/TP53 Status for Overall Survival in First-Line Monoimmunotherapy and Chemoimmunotherapy Treated Patients With Nonsquamous NSCLC in the Netherlands: A Brief Report

PS-20-007 PD-L1 expression in driver-mutated metastatic non-small cell lung cancer

PS-20-008 Predictive biomarker testing rates in patients with metastatic non-small cell lung cancer in The Netherlands

Read more

Press/media

NVVP magazine 2021-01

Moleculaire diagnostiek voor de detectie van RET- en NTRK-fusies bij kanker

Successful Molecular Tumor Board

Effectiveness of the UMCG Molecular Tumor Board

Detectie van fusiegenen: kwaliteitscontrole en nieuwe methodologie

Moleculaire Tumor Boards

cBioportal at HealtRI

Opening of the Molecualr Pathology Centre, Montreal, QC, 2014

Opening of the Molecular Pathology Center, Montreal, QC, Canada, 2014

Read more